162 related articles for article (PubMed ID: 31101757)
1. Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.
Taguchi M; Mishima H; Shiozawa Y; Hayashida C; Kinoshita A; Nannya Y; Makishima H; Horai M; Matsuo M; Sato S; Itonaga H; Kato T; Taniguchi H; Imanishi D; Imaizumi Y; Hata T; Takenaka M; Moriuchi Y; Shiraishi Y; Miyano S; Ogawa S; Yoshiura KI; Miyazaki Y
Haematologica; 2020; 105(2):358-365. PubMed ID: 31101757
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.
Horai M; Satoh S; Matsuo M; Iwanaga M; Horio K; Jo T; Takasaki Y; Kawaguchi Y; Tsushima H; Yoshida S; Taguchi M; Itonaga H; Sawayama Y; Taguchi J; Imaizumi Y; Hata T; Moriuchi Y; Haase D; Yoshiura KI; Miyazaki Y
Br J Haematol; 2018 Feb; 180(3):381-390. PubMed ID: 29265181
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.
Matsuo M; Iwanaga M; Kondo H; Soda M; Jo T; Horio K; Takasaki Y; Kawaguchi Y; Tsushima H; Imaizumi Y; Imanishi D; Taguchi J; Sawayama Y; Hata T; Miyazaki Y
Cancer Sci; 2016 Oct; 107(10):1484-1491. PubMed ID: 27487572
[TBL] [Abstract][Full Text] [Related]
4. [Radiation-induced hematopoietic disorders].
Ando K; Miyazaki Y
Rinsho Ketsueki; 2022; 63(9):981-990. PubMed ID: 36198562
[TBL] [Abstract][Full Text] [Related]
5. High frequency of AML1/RUNX1 point mutations in radiation-associated myelodysplastic syndrome around Semipalatinsk nuclear test site.
Zharlyganova D; Harada H; Harada Y; Shinkarev S; Zhumadilov Z; Zhunusova A; Tchaizhunusova NJ; Apsalikov KN; Kemaikin V; Zhumadilov K; Kawano N; Kimura A; Hoshi M
J Radiat Res; 2008 Sep; 49(5):549-55. PubMed ID: 18724045
[TBL] [Abstract][Full Text] [Related]
6. Impact of Nagasaki atomic bomb exposure on myelodysplastic syndrome patients who are treated with azacitidine.
Jo T; Horio K; Shigematsu K
Anticancer Res; 2015 May; 35(5):2929-33. PubMed ID: 25964578
[TBL] [Abstract][Full Text] [Related]
7. Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivors.
Iwanaga M; Hsu WL; Soda M; Takasaki Y; Tawara M; Joh T; Amenomori T; Yamamura M; Yoshida Y; Koba T; Miyazaki Y; Matsuo T; Preston DL; Suyama A; Kodama K; Tomonaga M
J Clin Oncol; 2011 Feb; 29(4):428-34. PubMed ID: 21149671
[TBL] [Abstract][Full Text] [Related]
8. [Chromosome 1 abnormalities at band 1p32 in two atomic bomb survivors with myelodysplastic syndrome].
Nakamura H; Hata T; Tagawa M; Atogami S; Tomonaga M; Sadamori N; Hayashi Y
Rinsho Ketsueki; 2000 Feb; 41(2):152-8. PubMed ID: 10723246
[TBL] [Abstract][Full Text] [Related]
9. Lessons from the atomic bomb about secondary MDS.
Hata T; Imanishi D; Miyazaki Y
Curr Hematol Malig Rep; 2014 Dec; 9(4):407-11. PubMed ID: 25240475
[TBL] [Abstract][Full Text] [Related]
10. Mutations of myelodysplastic syndromes (MDS): An update.
Ganguly BB; Kadam NN
Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.
Cortes J; O'Brien S; Kantarjian H; Cork A; Stass S; Freireich EJ; Keating M; Pierce S; Estey E
Leukemia; 1994 Dec; 8(12):2174-8. PubMed ID: 7808007
[TBL] [Abstract][Full Text] [Related]
12. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.
Harada H; Harada Y; Tanaka H; Kimura A; Inaba T
Blood; 2003 Jan; 101(2):673-80. PubMed ID: 12393679
[TBL] [Abstract][Full Text] [Related]
13. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
14. Late effect of atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes.
Tsushima H; Iwanaga M; Miyazaki Y
Int J Hematol; 2012 Mar; 95(3):232-8. PubMed ID: 22370711
[TBL] [Abstract][Full Text] [Related]
15. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal instability in acute myelocytic leukemia and myelodysplastic syndrome patients among atomic bomb survivors.
Nakanishi M; Tanaka K; Shintani T; Takahashi T; Kamada N
J Radiat Res; 1999 Jun; 40(2):159-67. PubMed ID: 10494147
[TBL] [Abstract][Full Text] [Related]
17. Genetic abnormalities and pathophysiology of MDS.
Hosono N
Int J Clin Oncol; 2019 Aug; 24(8):885-892. PubMed ID: 31093808
[TBL] [Abstract][Full Text] [Related]
18. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
Iwanaga M; Tomonaga M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndromes in Chernobyl clean-up workers.
Gluzman DF; Sklyarenko LM; Koval SV; Rodionova NK; Zavelevich MP; Ivanivskaya TS; Poludnenko LY; Ukrainskaya NI
Ann Hematol; 2015 Oct; 94(10):1639-43. PubMed ID: 26208666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
